{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T21:46:24Z","timestamp":1769031984006,"version":"3.49.0"},"reference-count":135,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Oncol. Rev."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pleural effusion, an atypical accumulation of fluid in the pleural space, has been identified as a potential indicator of several diseases, including lung cancer. The presence of biomarkers in malignant pleural effusion has been a subject of investigation; however, the expression of microRNAs has received limited attention. The objective of this study is to present a narrative review of the current scientific literature regarding the presence of microRNAs in malignant pleural effusion and their association as new biomarkers in the diagnosis of lung cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A comprehensive search was conducted using the databases: PubMed, ScienceDirect, and EBSCO to identify all original scientific articles published through 30 April 2025. The following terms were utilized in the search: \u201cMicroRNA AND pleural effusion AND lung cancer\u201d, \u201cmicroRNA AND pleural effusion AND lung adenocarcinoma\u201d, \u201cmicroRNA AND pleural effusion AND lung squamous cell carcinoma\u201d, \u201cmiRNA AND pleural effusion\u201d, miRNA AND pleural effusion AND lung cancer\u201d, \u201cmiRNA AND pleural effusion AND lung adenocarcinoma\u201d, \u201cmiRNA AND pleural effusion AND lung squamous cell carcinoma\u201d.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 17 studies were identified that distinguished between 106 microRNAs. These studies demonstrated the most significant overexpression and downexpression in lung cancer patients compared to patients without malignancy. However, eight of these studies distinguished between 17 microRNAs expressions and exhibited elevated area under the curve values, sensitivity, and specificity for the involvement in several hallmarks of lung cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The regulatory mechanisms governing microRNAs in malignant pleural effusion are intricate and involve multiple genes that play pivotal roles in several cancer mechanisms. These mechanisms encompass but are not limited to, processes such as cell growth, migration, drug resistance, proliferation, apoptosis, invasion, angiogenesis, and apoptosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/or.2025.1642661","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:42:07Z","timestamp":1768977727000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel approach in the identification of microRNAs in malignant pleural effusion for lung cancer diagnosis"],"prefix":"10.3389","volume":"19","author":[{"given":"Jes\u00fas","family":"Valencia-Cervantes","sequence":"first","affiliation":[{"name":"Departamento de Investigaci\u00f3n en Toxicolog\u00eda y Medicina Ambiental, Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas (INER)","place":["Mexico City, Mexico"]},{"name":"Estancias Posdoctorales por M\u00e9xico 2022 (1), Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n (SECIHTI)","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Ramirez-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmunobiolog\u00eda y Gen\u00e9tica, Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas (INER)","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita Isabel","family":"Palacios-Arreola","sequence":"additional","affiliation":[{"name":"Departamento de Investigaci\u00f3n en Toxicolog\u00eda y Medicina Ambiental, Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas (INER)","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Loaeza-Rom\u00e1n","sequence":"additional","affiliation":[{"name":"Departamento de Investigaci\u00f3n en Toxicolog\u00eda y Medicina Ambiental, Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas (INER)","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha Patricia","family":"Sierra-Vargas","sequence":"additional","affiliation":[{"name":"Departamento de Investigaci\u00f3n en Toxicolog\u00eda y Medicina Ambiental, Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas (INER)","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"B1","volume-title":"Pleural effusionStatPearls","author":"Krishna","year":"2025"},{"key":"B2","doi-asserted-by":"publisher","first-page":"230145","DOI":"10.1183\/20734735.0145-2023","article-title":"Malignant pleural disease","volume":"19","author":"Piggott","year":"2023","journal-title":"Breathe (Sheff)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.21037\/amj-2019-mpe-05","article-title":"Etiopathogenesis of malignant pleural effusion","volume":"6","author":"Jovanovic","year":"2021","journal-title":"AME Med J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc3775","article-title":"Non-small-cell lung cancers: a heterogeneous set of diseases","volume":"14","author":"Chen","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.21037\/jtd.2017.11.62","article-title":"Diagnostic accuracy of tumor markers for malignant pleural effusion: a derivation and validation study","volume":"9","author":"Zhai","year":"2017","journal-title":"J Thorac Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.21037\/tlcr-20-1111","article-title":"Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review","volume":"10","author":"Zhang","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"107559","DOI":"10.1016\/j.compbiolchem","article-title":"Exploring the value of pleural fluid biomarkers for complementary pleural effusion disease examination","volume":"94","author":"Thi Huyen","year":"2021","journal-title":"Comput Biol Chem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1111\/1759-7714.14996","article-title":"Long-term stability of pleural fluid carcinoembryonic antigen and its effect on the diagnostic accuracy for malignant pleural effusion","volume":"14","author":"Yang","year":"2023","journal-title":"Thorac Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s13353-023-00750-2","article-title":"MicroRNA in lung cancer-a novel potential way for early diagnosis and therapy","volume":"64","author":"Frydrychowicz","year":"2023","journal-title":"J Appl Genet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/cells9020276","article-title":"miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis","volume":"9","author":"Condrat","year":"2020","journal-title":"Cells"},{"key":"B13","doi-asserted-by":"publisher","first-page":"638","DOI":"10.7150\/jca.21180","article-title":"Human salivary microRNAs in cancer","volume":"9","author":"Rapado-Gonz\u00e1lez","year":"2018","journal-title":"J Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct Target Ther"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/genes14071375","article-title":"miRNAs: potential as biomarkers and therapeutic targets for cancer","volume":"14","author":"Chakrabortty","year":"2023","journal-title":"Genes (Basel)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"11389","DOI":"10.3390\/ijms231911389","article-title":"Overview of MicroRNAs as diagnostic and prognostic biomarkers for high-incidence cancers in 2021","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/modpathol.2010.152","article-title":"miRNA expression profiling of lung adenocarcinomas: correlation with mutational status","volume":"23","author":"Dacic","year":"2010","journal-title":"Mod Pathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1517\/17530059.2012.672970","article-title":"Applications of MicroRNAs in the diagnosis and prognosis of lung cancer","volume":"6","author":"Shen","year":"2012","journal-title":"Expert Opin Med Diagn"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.3390\/ijms23052805","article-title":"miRNAs in cancer","volume":"23","author":"Smolarz","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/s12276-023-01050-9","article-title":"MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies","volume":"55","author":"Kim","year":"2023","journal-title":"Exp Mol Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/ijc.28054","article-title":"Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion","volume":"133","author":"Han","year":"2013","journal-title":"Int J Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4143\/crt.2014.46.2.178","article-title":"Diagnostic value of circulating extracellular miR-134, miR-185, and miR-22 levels in lung adenocarcinoma-associated malignant pleural effusion","volume":"46","author":"Shin","year":"2014","journal-title":"Cancer Res Treat"},{"key":"B23","doi-asserted-by":"publisher","first-page":"635748","DOI":"10.1155\/2015\/635748","article-title":"MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion","volume":"2015","author":"Ak","year":"2015","journal-title":"Biomed Res Int"},{"key":"B24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/cncy.21646","article-title":"Young investigator challenge: microRNA-21\/microRNA-126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology","volume":"124","author":"Cappellesso","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e8361","DOI":"10.1097\/MD.0000000000008361","article-title":"Identification of differential expressed PE exosomal miRNA in lung adenocarcinoma, tuberculosis, and other benign lesions","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.lungcan.2018.07.018","article-title":"Exosomal RNA-profiling of pleural effusions identifies adenocarcinoma patients through elevated miR-200 and LCN2 expression","volume":"124","author":"Hydbring","year":"2018","journal-title":"Lung Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/icvts\/ivx327","article-title":"Combination of DNA ploidy analysis and miR-21 or miR-24 in screening malignant pleural effusion","volume":"26","author":"Liu","year":"2018","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"B28","doi-asserted-by":"publisher","first-page":"6707","DOI":"10.21873\/anticanres.13039","article-title":"Exosomal MicroRNA expression profiling in patients with lung adenocarcinoma-associated malignant pleural effusion","volume":"38","author":"Tamiya","year":"2018","journal-title":"Anticancer Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"8628612","DOI":"10.1155\/2019\/8628612","article-title":"MicroRNA signatures in malignant pleural mesothelioma effusions","volume":"2019","author":"Birnie","year":"2019","journal-title":"Dis Markers"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1097\/CM9.0000000000000517","article-title":"Downregulation of miR-4772-3p promotes enhanced regulatory T cell capacity in malignant pleural effusion by elevating helios levels","volume":"132","author":"Yu","year":"2019","journal-title":"Chin Med J (Engl)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"15057","DOI":"10.1038\/s41598-019-51578-y","article-title":"EV-associated miRNAs from pleural lavage as potential diagnostic biomarkers in lung cancer","volume":"9","author":"Roman-Canal","year":"2019","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41065-020-00119-z","article-title":"Identification of differentially expressed miRNAs in differentiating benign from malignant pleural effusion","volume":"157","author":"Bao","year":"2020","journal-title":"Hereditas"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.3390\/genes13112159","article-title":"Extracellular vesicle MicroRNA in malignant pleural effusion","volume":"13","author":"Shojaee","year":"2022","journal-title":"Genes (Basel)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3233\/CBM-210090","article-title":"Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion","volume":"33","author":"Zhu","year":"2022","journal-title":"Cancer Biomark"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e30646","DOI":"10.1016\/j.heliyon.2024.e30646","article-title":"A novel microRNA miR-4433a-3p as a potential diagnostic biomarker for lung adenocarcinoma","volume":"10","author":"Sun","year":"2024","journal-title":"Heliyon"},{"key":"B36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.21037\/tlcr-24-945","article-title":"Potential utility of miRNAs derived from pleural fluid extracellular vesicles to differentiate between benign and malignant pleural effusions","volume":"14","author":"Chee","year":"2025","journal-title":"Transl Lung Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.clinbiochem.2010.11.002","article-title":"Cell-free miR-24 and miR-30d, potential diagnostic biomarkers in malignant effusions","volume":"44","author":"Xie","year":"2011","journal-title":"Clin Biochem"},{"key":"B38","doi-asserted-by":"publisher","first-page":"6759","DOI":"10.26355\/eurrev_202006_21664","article-title":"The expression and clinical significance of B7-H3 and miR-145 in lung cancer patients with malignant pleural effusion","volume":"24","author":"Huang","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1186\/s12967-023-04649-8","article-title":"The important role of miR-1-3p in cancers","volume":"21","author":"Dai","year":"2023","journal-title":"J Transl Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fonc.2019.00120","article-title":"MiR-1-3p inhibits lung adenocarcinoma cell tumorigenesis via targeting protein regulator of cytokinesis 1","volume":"9","author":"Li","year":"2019","journal-title":"Front Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1111\/jcmm.13629","article-title":"miR-1-3p and miR-206 sensitizes HGF-induced gefitinib-resistant human lung cancer cells through inhibition of c-Met signalling and EMT","volume":"22","author":"Jiao","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7150\/ijms.44377","article-title":"miR-19 regulates the expression of interferon-induced genes and MHC class I genes in human cancer cells","volume":"17","author":"Li","year":"2020","journal-title":"Int J Med Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/labinvest.2015.76","article-title":"MicroRNA-19 triggers epithelial-mesenchymal transition of lung cancer cells accompanied by growth inhibition","volume":"95","author":"Li","year":"2015","journal-title":"Lab Invest"},{"key":"B44","doi-asserted-by":"publisher","first-page":"8865","DOI":"10.2147\/OTT.S181433","article-title":"miRNA-19 promotes non-small-cell lung cancer cell proliferation via inhibiting CBX7 expression","volume":"11","author":"Peng","year":"2018","journal-title":"Onco Targets Ther"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.3892\/ol.2016.4881","article-title":"miR-19a\/b modulates lung cancer cells metastasis through suppression of MXD1 expression","volume":"12","author":"Hu","year":"2016","journal-title":"Oncol Lett"},{"key":"B46","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1093\/procel\/pwad062","article-title":"Oncogenic miR-19a and miR-19b co-regulate tumor suppressor MTUS1 to promote cell proliferation and migration in lung cancer","volume":"15","author":"Gu","year":"2024","journal-title":"Protein Cell"},{"key":"B47","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.omtn.2020.03.003","article-title":"The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics","volume":"20","author":"Bautista-S\u00e1nchez","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"B48","doi-asserted-by":"publisher","first-page":"12085","DOI":"10.1073\/pnas.0905234106","article-title":"MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers","volume":"106","author":"Seike","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B49","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11670-011-0123-2","article-title":"Reduction of plasma MicroRNA-21 is associated with chemotherapeutic response in patients with non-small cell lung cancer","volume":"23","author":"Wei","year":"2011","journal-title":"Chin J Cancer Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12935-019-0941-8","article-title":"miR-21 promotes non-small cell lung cancer cells growth by regulating fatty acid metabolism","volume":"19","author":"Ni","year":"2019","journal-title":"Cancer Cell Int"},{"key":"B51","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3892\/ol.2019.10337","article-title":"High expression of miR-155 and miR-21 in the recurrence or metastasis of non-small cell lung cancer","volume":"18","author":"Xu","year":"2019","journal-title":"Oncol Lett"},{"key":"B52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/genes16020133","article-title":"Exploring miR-21 knock-out using CRISPR\/cas as a treatment for lung cancer","volume":"16","author":"Lara","year":"2025","journal-title":"Genes (Basel)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3892\/ijo.2016.3811","article-title":"Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer","volume":"50","author":"Wang","year":"2017","journal-title":"Int J Oncol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.26355\/eurrev_201708_13271","article-title":"MiR-22 inhibits lung cancer cell EMT and invasion through targeting snail","volume":"21","author":"Zhang","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.omtn.2021.10.003","article-title":"Suppression of endothelial miR-22 mediates non-small cell lung cancer cell-induced angiogenesis","volume":"26","author":"Gu","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"B56","first-page":"1221","article-title":"MiR-22-3p suppresses cell growth via MET\/STAT3 signaling in lung cancer","volume":"13","author":"Yang","year":"2021","journal-title":"Am J Transl Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1084\/jem.20150990","article-title":"miR-23\u223c27\u223c24 clusters control effector T cell differentiation and function","volume":"213","author":"Cho","year":"2016","journal-title":"J Exp Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jcp.24422","article-title":"Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer","volume":"229","author":"Franchina","year":"2014","journal-title":"J Cell Physiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1111\/1759-7714.12824","article-title":"Inhibition of miR-24 suppresses malignancy of human non-small cell lung cancer cells by targeting WWOX in vitro and in vivo","volume":"9","author":"Wang","year":"2018","journal-title":"Thorac Cancer"},{"key":"B60","first-page":"1413","article-title":"MiR-24 promotes migration and invasion of non-small cell lung cancer by targeting ZNF367","volume":"23","author":"Liu","year":"2018","journal-title":"J BUON"},{"key":"B61","doi-asserted-by":"publisher","first-page":"21580","DOI":"10.18632\/oncotarget.24662","article-title":"A myriad of roles of miR-25 in health and disease","volume":"9","author":"S\u00e1rk\u00f6zy","year":"2018","journal-title":"Oncotarget"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.7314\/apjcp.2014.15.3.1197","article-title":"Prognostic implications for high expression of MiR-25 in lung adenocarcinomas of female non-smokers","volume":"15","author":"Xu","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"B63","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1093\/carcin\/bgv068","article-title":"miR-25 targets the modulator of apoptosis 1 gene in lung cancer","volume":"36","author":"Wu","year":"2015","journal-title":"Carcinogenesis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.3892\/mmr.2018.8772","article-title":"miR-25 enhances cell migration and invasion in non-small-cell lung cancer cells via ERK signaling pathway by inhibiting KLF4","volume":"17","author":"Ding","year":"2018","journal-title":"Mol Med Rep"},{"key":"B65","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/21655979.2019.1632668","article-title":"miR-25 promotes invasion of human non-small cell lung cancer via CDH1","volume":"10","author":"Liu","year":"2019","journal-title":"Bioengineered"},{"key":"B66","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.26355\/eurrev_201906_18191","article-title":"Low plasma miR-25 expression is a favorite prognosis factor in non-small cell lung cancer","volume":"23","author":"Zhang","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B67","doi-asserted-by":"publisher","first-page":"9719723","DOI":"10.1155\/2019\/9719723","article-title":"miR-25 promotes cell proliferation, migration, and invasion of non-small-cell lung cancer by targeting the LATS2\/YAP signaling pathway","volume":"2019","author":"Wu","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"B68","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3892\/ol.2020.12053","article-title":"Analysis of the expression levels and clinical value of miR-365 and miR-25 in serum of patients with non-small cell lung cancer","volume":"20","author":"Huang","year":"2020","journal-title":"Oncol Lett"},{"key":"B69","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3892\/ol.2020.12099","article-title":"A three serum miRNA panel as diagnostic biomarkers of radiotherapy-related metastasis in non-small cell lung cancer","volume":"20","author":"Lv","year":"2020","journal-title":"Oncol Lett"},{"key":"B70","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1152\/physiolgenomics.00141.2011","article-title":"The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury","volume":"44","author":"Kriegel","year":"2012","journal-title":"Physiol Genomics"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e70192","DOI":"10.1371\/journal.pone.0070192","article-title":"miRNA-29c suppresses lung cancer cell adhesion to extracellular matrix and metastasis by targeting integrin \u03b21 and matrix metalloproteinase2 (MMP2)","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e87780","DOI":"10.1371\/journal.pone.0087780","article-title":"Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer","volume":"9","author":"Zhu","year":"2014","journal-title":"PLoS One"},{"key":"B73","doi-asserted-by":"publisher","first-page":"85905","DOI":"10.18632\/oncotarget.13137","article-title":"A regulatory loop involving miR-29c and Sp1 elevates the TGF-\u03b21 mediated epithelial-to-mesenchymal transition in lung cancer","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"B74","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12943-017-0620-0","article-title":"MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma","volume":"16","author":"Liu","year":"2017","journal-title":"Mol Cancer"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1010428317695010","DOI":"10.1177\/1010428317695010","article-title":"Tumor suppressor miR-29c regulates radioresistance in lung cancer cells","volume":"39","author":"Arechaga-Ocampo","year":"2017","journal-title":"Tumour Biol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"8007","DOI":"10.1038\/s41598-018-26381-w","article-title":"MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K\/Akt pathway","volume":"8","author":"Sun","year":"2018","journal-title":"Sci Rep"},{"key":"B77","doi-asserted-by":"publisher","first-page":"6705","DOI":"10.3892\/mmr.2018.8678","article-title":"MicroRNA-29c inhibits proliferation and promotes apoptosis in non-small cell lung cancer cells by targeting VEGFA","volume":"17","author":"Zhan","year":"2018","journal-title":"Mol Med Rep"},{"key":"B78","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1186\/s12935-021-02332-w","article-title":"Downregulation of miR-29c promotes muscle wasting by modulating the activity of leukemia inhibitory factor in lung cancer cachexia","volume":"21","author":"Xie","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B79","doi-asserted-by":"publisher","first-page":"829435","DOI":"10.3389\/fcell.2022.829435","article-title":"miR-30d-5p: a non-coding RNA with potential diagnostic, prognostic and therapeutic applications","volume":"10","author":"Zhao","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.bbrc.2012.12.083","article-title":"mir-30d regulates multiple genes in the autophagy pathway and impairs autophagy process in human cancer cells","volume":"431","author":"Yang","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"B81","first-page":"98","article-title":"Clinically significant dysregulation of hsa-miR-30d-5p and hsa-let-7b expression in patients with surgically resected non-small cell lung cancer","volume":"10","author":"Hosseini","year":"2018","journal-title":"Avicenna J Med Biotechnol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s10529-017-2428-9","article-title":"Non-small cell lung cancer: miR-30d suppresses tumor invasion and migration by directly targeting NFIB","volume":"39","author":"Wu","year":"2017","journal-title":"Biotechnol Lett"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1159\/000494875","article-title":"Expression signature and role of miR-30d-5p in non-small cell lung cancer: a comprehensive study based on in silico analysis of public databases and in vitro experiments","volume":"50","author":"Gao","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B84","doi-asserted-by":"publisher","first-page":"857986","DOI":"10.3389\/fgene.2022.857986","article-title":"LncRNA SOX2-OT\/miR-30d-5p\/PDK1 regulates PD-L1 checkpoint through the mTOR signaling pathway to promote non-small cell lung cancer progression and immune escape","volume":"13","author":"Chen","year":"2022","journal-title":"Front Genet"},{"key":"B85","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3892\/ol.2020.12296","article-title":"MicroRNA-126: a new and promising player in lung cancer","volume":"21","author":"Chen","year":"2021","journal-title":"Oncol Lett"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e42978","DOI":"10.1371\/journal.pone.0042978","article-title":"MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"B87","doi-asserted-by":"publisher","first-page":"15277","DOI":"10.1038\/s41598-017-15475-6","article-title":"Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression","volume":"7","author":"Grimolizzi","year":"2017","journal-title":"Sci Rep"},{"key":"B88","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12935-021-01974-0","article-title":"Exosomal miR-126 blocks the development of non-small cell lung cancer through the inhibition of ITGA6","volume":"21","author":"Li","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B89","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.omtn.2016.11.003","article-title":"miR-134: a human cancer suppressor?","volume":"6","author":"Pan","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"B90","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1016\/j.febslet.2012.09.016","article-title":"miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells","volume":"586","author":"Li","year":"2012","journal-title":"FEBS Lett"},{"key":"B91","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.bbrc.2015.07.021","article-title":"MicroRNA-134 regulates lung cancer cell H69 growth and apoptosis by targeting WWOX gene and suppressing the ERK1\/2 signaling pathway","volume":"464","author":"Chen","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B92","doi-asserted-by":"publisher","first-page":"35960","DOI":"10.18632\/oncotarget.8482","article-title":"Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1111\/jcmm.12889","article-title":"miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor","volume":"20","author":"Qin","year":"2016","journal-title":"J Cell Mol Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3892\/ol.2017.5574","article-title":"MicroRNA-134 reverses multidrug resistance in human lung adenocarcinoma cells by targeting FOXM1","volume":"13","author":"Li","year":"2017","journal-title":"Oncol Lett"},{"key":"B95","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.omtn.2019.09.025","article-title":"miR-134-5p promotes stage I lung adenocarcinoma metastasis and chemoresistance by targeting DAB2","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"B96","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.7150\/jca.46293","article-title":"MicroRNA-144: a novel biological marker and potential therapeutic target in human solid cancers","volume":"11","author":"Zhou","year":"2020","journal-title":"J Cancer"},{"key":"B97","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1159\/000369755","article-title":"MiR-144 inhibits proliferation and induces apoptosis and autophagy in lung cancer cells by targeting TIGAR","volume":"35","author":"Chen","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"B98","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.3892\/ol.2016.4468","article-title":"Downregulating microRNA-144 mediates a metabolic shift in lung cancer cells by regulating GLUT1 expression","volume":"11","author":"Liu","year":"2016","journal-title":"Oncol Lett"},{"key":"B99","doi-asserted-by":"publisher","first-page":"5109497","DOI":"10.1155\/2018\/5109497","article-title":"miR-144-5p enhances the radiosensitivity of non-small-cell lung cancer cells via targeting ATF2","volume":"2018","author":"Song","year":"2018","journal-title":"Biomed Res Int"},{"key":"B100","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2147\/CMAR.S191696","article-title":"Function of microRNA-145 and mechanisms underlying its role in malignant tumor diagnosis and treatment","volume":"11","author":"Ye","year":"2019","journal-title":"Cancer Manag Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1756-9966-29-151","article-title":"miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc","volume":"29","author":"Chen","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1183\/09031936.00048712","article-title":"Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer","volume":"41","author":"Campayo","year":"2013","journal-title":"Eur Respir J"},{"key":"B103","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/15384047.2016.1139242","article-title":"Expression levels of microRNA-145 and microRNA-10b are associated with metastasis in non-small cell lung cancer","volume":"17","author":"Li","year":"2016","journal-title":"Cancer Biol Ther"},{"key":"B104","doi-asserted-by":"publisher","first-page":"72084","DOI":"10.18632\/oncotarget.12290","article-title":"Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma","volume":"7","author":"Mataki","year":"2016","journal-title":"Oncotarget"},{"key":"B105","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12935-018-0601-4","article-title":"miR-145 and miR-497 suppress TGF-\u03b2-induced epithelial-mesenchymal transition of non-small cell lung cancer by targeting MTDH","volume":"18","author":"Yin","year":"2018","journal-title":"Cancer Cell Int"},{"key":"B106","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3892\/ijo.2018.4393","article-title":"miR 145 inhibits human non small-cell lung cancer growth by dual-targeting RIOK2 and NOB1","volume":"53","author":"Liu","year":"2018","journal-title":"Int J Oncol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3892\/ol.2021.13130","article-title":"Diagnostic and prognostic value of serum miR-145 and vascular endothelial growth factor in non-small cell lung cancer","volume":"23","author":"Geater","year":"2022","journal-title":"Oncol Lett"},{"key":"B108","doi-asserted-by":"publisher","first-page":"10022","DOI":"10.3390\/ijms241210022","article-title":"miR-145 as a potential biomarker and therapeutic target in patients with non-small cell lung cancer","volume":"24","author":"Cho","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B109","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12935-023-03105-3","article-title":"Diverse activity of miR-150 in tumor development: shedding light on the potential mechanisms","volume":"23","author":"Ameri","year":"2023","journal-title":"Cancer Cell Int"},{"key":"B110","doi-asserted-by":"publisher","first-page":"39001","DOI":"10.1038\/srep39001","article-title":"MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"B111","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.omtn.2019.04.017","article-title":"miR-150-5p inhibits non-small-cell lung cancer metastasis and recurrence by targeting HMGA2 and \u03b2-Catenin signaling","volume":"16","author":"Dai","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"B112","doi-asserted-by":"publisher","first-page":"153145","DOI":"10.1016\/j.prp.2020.153145","article-title":"Higher expression of miR-150-5p promotes tumorigenesis by suppressing LKB1 in non-small cell lung cancer","volume":"216","author":"Wu","year":"2020","journal-title":"Pathol Res Pract"},{"key":"B113","doi-asserted-by":"publisher","first-page":"7173","DOI":"10.1093\/nar\/gkv703","article-title":"The microRNA-183 cluster: the family that plays together stays together","volume":"43","author":"Dambal","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B114","doi-asserted-by":"publisher","first-page":"740","DOI":"10.18632\/oncotarget.1608","article-title":"Sp1-mediated microRNA-182 expression regulates lung cancer progression","volume":"5","author":"Yang","year":"2014","journal-title":"Oncotarget"},{"key":"B115","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/1440-1681.13041","article-title":"MiR-182 enhances radioresistance in non-small cell lung cancer cells by regulating FOXO3","volume":"46","author":"Chen","year":"2019","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e0153046","DOI":"10.1371\/journal.pone.0153046","article-title":"Diagnostic value of serum miR-182, miR-183, miR-210, and miR-126 levels in patients with early-stage non-small cell lung cancer","volume":"11","author":"Zhu","year":"2016","journal-title":"PLoS One"},{"key":"B117","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3892\/etm.2019.8074","article-title":"Upregulated miRNA-182-5p expression in tumor tissue and peripheral blood samples from patients with non-small cell lung cancer is associated with downregulated caspase 2 expression","volume":"19","author":"Yang","year":"2020","journal-title":"Exp Ther Med"},{"key":"B118","doi-asserted-by":"publisher","first-page":"7120","DOI":"10.7150\/jca.60419","article-title":"MiR-182-5p promotes the metastasis and epithelial-mesenchymal transition in non-small cell lung cancer by targeting EPAS1","volume":"12","author":"Yang","year":"2021","journal-title":"J Cancer"},{"key":"B119","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41419-023-05819-8","article-title":"A novel microRNA-182\/Interleukin-8 regulatory axis controls osteolytic bone metastasis of lung cancer","volume":"14","author":"Zhao","year":"2023","journal-title":"Cell Death Dis"},{"key":"B120","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/ncrna8050067","article-title":"The roles of microRNA miR-185 in digestive tract cancers","volume":"8","author":"Babaeenezhad","year":"2022","journal-title":"Noncoding RNA"},{"key":"B121","first-page":"4697","article-title":"MicroRNA-185-5p modulates chemosensitivity of human non-small cell lung cancer to cisplatin via targeting ABCC1","volume":"20","author":"Pei","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B122","doi-asserted-by":"publisher","first-page":"677860","DOI":"10.3389\/fcell.2021.677860","article-title":"Inhibition of miR-185-3p confers erlotinib resistance through upregulation of PFKL\/MET in lung cancers","volume":"9","author":"Li","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13019-023-02342-x","article-title":"MicroRNA-185-5p targets tyrosine 3-monooxygenase\/tryptophan 5-monooxygenase activation protein zeta to regulate non-small cell lung cancer progression","volume":"18","author":"Ma","year":"2023","journal-title":"J Cardiothorac Surg"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1533033820973276","DOI":"10.1177\/1533033820973276","article-title":"Serum miR-185 is a diagnostic and prognostic biomarker for non-small cell lung cancer","volume":"19","author":"Liu","year":"2020","journal-title":"Technol Cancer Res Treat"},{"key":"B125","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12957-018-1320-y","article-title":"Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR","volume":"16","author":"Liang","year":"2018","journal-title":"World J Surg Oncol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.3892\/ol.2019.10610","article-title":"Clinical value of microRNA-198-5p downregulation in lung adenocarcinoma and its potential pathways","volume":"18","author":"Wang","year":"2019","journal-title":"Oncol Lett"},{"key":"B127","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/1440-1681.13154","article-title":"MicroRNA-198-5p inhibits the migration and invasion of non-small lung cancer cells by targeting fucosyltransferase 8","volume":"46","author":"Wang","year":"2019","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.21037\/tlcr-2025-844","article-title":"MicroRNA expression in pleural fluid as a diagnostic biomarker of malignant pleural effusion: promise, pragmatism, and the path forward","volume":"14","author":"Porcel","year":"2025","journal-title":"Transl Lung Cancer Res"},{"key":"B129","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.arbres.2016.12.013","article-title":"Utilidad de la medici\u00f3n de CEA y CA 15-3 en los exudados pleurales no purulentos para diagnosticar malignidad: experiencia de un \u00fanico centro","volume":"53","author":"Porcel","year":"2017","journal-title":"Archivos de Bronconeumolog\u00eda"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1002\/cam4.2928","article-title":"Clinicopathological significance of microRNA-21 in extracellular vesicles of pleural lavage fluid of lung adenocarcinoma and its functions inducing the mesothelial to mesenchymal transition","volume":"9","author":"Watabe","year":"2020","journal-title":"Cancer Med"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.21037\/tlcr-2024-1205","article-title":"Exosomal miR-182-5p is a potential diagnostic marker for malignant pleural effusion","volume":"14","author":"Zhao","year":"2025","journal-title":"Transl Lung Cancer Res"},{"key":"B132","doi-asserted-by":"publisher","first-page":"e43268","DOI":"10.1371\/journal.pone.0043268","article-title":"Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"B133","doi-asserted-by":"publisher","first-page":"14022","DOI":"10.3390\/ijms241814022","article-title":"MicroRNAs present in malignant pleural fluid increase the migration of normal mesothelial cells in vitro and may help discriminate between benign and malignant effusions","volume":"24","author":"Marqu\u00e9s","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B134","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/CBF.S55358","article-title":"MicroRNA signatures as clinical biomarkers in lung cancer","volume":"27","author":"Markou","year":"2015","journal-title":"Dove Press"},{"key":"B135","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.3390\/ijms26083736","article-title":"The role of microRNAs in lung cancer: mechanisms, diagnostics and therapeutic potential","volume":"26","author":"Bartoszewska","year":"2025","journal-title":"Int J Mol Sci"}],"container-title":["Oncology Reviews"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/or.2025.1642661\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:42:09Z","timestamp":1768977729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/or.2025.1642661\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":135,"alternative-id":["10.3389\/or.2025.1642661"],"URL":"https:\/\/doi.org\/10.3389\/or.2025.1642661","relation":{},"ISSN":["1970-5557"],"issn-type":[{"value":"1970-5557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"1642661"}}